Torbjörn Wärnheim
Plus aucun poste en cours
Fortune : 12 873 $ au 30/04/2024
Profil
Torbjörn Wärnheim worked as an Executive VP and Manager of Research & Development at Moberg Pharma AB from 2019 to 2021.
He also worked as a Vice President of Research & Development at Fresenius Kabi AB.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OLINK HOLDING AB
0,00% | 05/02/2024 | 558 ( 0,00% ) | 12 873 $ | 30/04/2024 |
Anciens postes connus de Torbjörn Wärnheim
| Sociétés | Poste | Fin |
|---|---|---|
| MOBERG PHARMA AB | Directeur Technique/Scientifique/R&D | 01/09/2021 |
Fresenius Kabi AB
 Fresenius Kabi AB Medical SpecialtiesHealth Technology Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MOBERG PHARMA AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Fresenius Kabi AB
Fresenius Kabi AB Medical SpecialtiesHealth Technology Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden. | Health Technology |
